Development and fine-tuning of a scale down model for process characterization studies of a monoclonal antibody upstream production process

BMC Proceedings

Meeting Abstract

Mareike Harmsen¹  Jimmy Stofferis¹  Laetitia Malphettes¹ 

[1] Cell Culture Process Development Group, Biological Process Development, UCB Pharma S.A, Braine-l’Alleud, 1420, Belgium;

关键词: Commercial Scale;    Viable Cell Density;    Cell Culture Process;    Scale Bioreactor;    Product Quality Attribute;   

DOI  :  10.1186/1753-6561-5-S8-P70

来源: Springer

【 授权许可】

CC BY   
© Harmsen et al; licensee BioMed Central Ltd. 2011